Table 1 Descriptive characteristics of statin users and never-users.
SMC (n = 52 220 women) | COSM (n = 40 713 men) | |||
|---|---|---|---|---|
Statin users | Never-users | Statin users | Never-users | |
Number of women/men | 19 323 | 32 987 | 17 854 | 22 859 |
Age, mean (SD) | 68.4 (7.8) | 69.5 (9.8) | 69.5 (8.5) | 66.6 (9.7) |
Body mass index, mean (SD) | 25.6 (4.0) | 24.7 (3.9) | 26.3 (3.3) | 25.4 (3.1) |
Metabolic equivalents (METs, in 1998) | 42.4 (4.8) | 42.5 (4.7) | 41.5 (4.5) | 41.7 (4.9) |
Charlson weighted comorbidity index, mean (SD) | 0.29 (0.72) | 0.23 (0.64) | 0.29 (0.65) | 0.12 (0.43) |
Energy intake (kcal/day) | 1715 (577) | 1731 (582) | 2621 (820) | 2714 (832) |
Pack-years of smoking, mean (SD) | 11.5 (10.5) | 10.6 (10.1) | 13.4 (15.9) | 10.5 (14.2) |
Education, n (%) | ||||
≤9 years | 12 751 (70.0) | 21 944 (66.5) | 10 078 (72.0) | 16 603 (65.5) |
10–12 years | 3175 (16.4) | 5412 (16.4) | 1815 (13.0) | 3910 (15.4) |
>12 years | 2585 (13.4) | 5458 (16.6) | 2045 (14.6) | 4735 (18.7) |
Vocational | 38 (0.2) | 82 (0.2) | 57 (0.4) | 84 (0.3) |
Corticosteroid use, n (%) | 1010 (5.2) | 1540 (4.7) | 3538 (19.8) | 3710 (16.2) |
Quinolone use, n (%) | 2962 (15.3) | 4438 (13.5) | 6062 (34.0) | 6516 (28.5) |
Diabetes mellitus, n (%) | 2618 (13.6) | 1398 (4.2) | 3963 (22.2) | 1332 (5.8) |
Renal insufficiency, n (%) | 455 (2.4) | 371 (1.1) | 1002 (5.6) | 547 (2.4) |
Statin use, n (%)* | ||||
Simvastatin | 13 266 (68.7) | NA | 12 256 (68.7) | NA |
Pravastatin | 415 (2.2) | NA | 243 (1.4) | NA |
Fluvastatin | 43 (0.22) | NA | 26 (0.2) | NA |
Atorvastatin | 4325 (22.4) | NA | 4584 (25.7) | NA |
Rosuvastatin | 775 (4.0) | NA | 745 (4.2) | NA |
